World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
29699
World Ranking
10551
National Ranking
1012

David Back publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David Back sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 645 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David Back D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David Back sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David Back is affiliated with the University of Liverpool in the United Kingdom and specializes in medical research with a focus on infectious diseases and pharmacology. Their publication record encompasses a range of topics including drug metabolism, HIV/AIDS treatment, and clinical studies related to COVID-19.

Back has contributed to several recent papers, including:

  • "Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications," 2022, Clinical Pharmacology & Therapeutics
  • "The challenge of HIV treatment in an era of polypharmacy," 2020, Journal of the International AIDS Society
  • "Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics," 2020, Clinical Pharmacology & Therapeutics
  • "Pharmacokinetics and Drug-Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine," 2021, Clinical Pharmacokinetics
  • "Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect," 2020, Journal of Antimicrobial Chemotherapy

Their frequent co-authors include:

  • Catia Marzolini
  • Saye Khoo
  • Fiona Marra
  • Alison Boyle
  • Sara Gibbons

Back publishes frequently in journals such as:

  • Journal of Antimicrobial Chemotherapy
  • Clinical Pharmacology & Therapeutics
  • British Journal of Clinical Pharmacology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Cerebral Blood Flow & Metabolism

The main fields of study for Back's work are within medicine, focusing especially on subfields including:

  • Infectious Diseases
  • Pharmacology
  • Epidemiology
  • Molecular Biology
  • Computational Theory and Mathematics

The main research topics covered by Back's publications include:

  • COVID-19 Clinical Research Studies
  • Pharmacogenetics and Drug Metabolism
  • HIV/AIDS drug development and treatment
  • SARS-CoV-2 and COVID-19 Research
  • Pharmacological Receptor Mechanisms and Effects
  • Drug-Induced Hepatotoxicity and Protection
  • Pneumocystis jirovecii pneumonia detection and treatment

Best Publications

  • Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

    Jacques Fellay;Catia Marzolini;Emma R. Meaden;David J. Back

  • Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes

    Victoria A. Eagling;John F. Tjia;David J. Back

  • Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.

    V. A. Eagling;D. J. Back;M. G. Barry

  • Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV Infection

    Michael Barry;Fiona Mulcahy;Concepta Merry;Sara Gibbons

  • Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations

    Michael Barry;Sara Gibbons;David Back;Fiona Mulcahy

  • St John's Wort increases expression of P-glycoprotein: Implications for drug interactions

    Martina Hennessy;D Kelleher;J P Spiers;M Barry

  • Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients.

    Concepta Merry;Michael G. Barry;Fiona Mulcahy;Kathryn L. Halifax

  • Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.

    L M Forrester;C J Henderson;M J Glancey;D J Back

  • Predictors of Kidney Tubular Dysfunction in HIV-Infected Patients Treated with Tenofovir: A Pharmacogenetic Study

    Sonia Rodríguez-Nóvoa;Pablo Labarga;Vincent Soriano;Deirdre Egan

  • Pharmacokinetic Drug Interactions with Oral Contraceptives

    David J. Back;Michael LʼE. Orme

  • Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.

    Catia Marzolini;Luigia Elzi;Sara Gibbons;Rainer Weber

  • Principles and practice of HIV-protease inhibitor pharmacoenhancement.

    GJ Moyle;D Back

  • Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.

    DJ Back;JF Tjia

  • Therapeutic drug monitoring in HIV infection: current status and future directions.

    David J. Back;Giorgio Gatti;Courtney Fletcher;Rodolphe Garaffo

  • Ageing with HIV: medication use and risk for potential drug–drug interactions

    Catia Marzolini;David Back;Rainer Weber;Hansjakob Furrer

  • The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.

    P. Crawford;DJ Chadwick;C. Martin;J. Tjia

  • Darunavir: pharmacokinetics and drug interactions.

    David Back;Vanitha Sekar;Richard M W Hoetelmans

  • Clinical pharmacokinetics of oral contraceptive steroids.

    Orme Ml;Back Dj;Breckenridge Am

  • Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

    Christoph Wyen;Heidy Hendra;Martin Vogel;Christian Hoffmann

  • Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.

    Louise Profit;Victoria A. Eagling;David J. Back

Frequent Co-Authors

Saye Khoo
Saye Khoo University of Liverpool
Marta Boffito
Marta Boffito Imperial College London
Alan Winston
Alan Winston Imperial College London
Brian Gazzard
Brian Gazzard St Bartholomew's Hospital
Graeme Moyle
Graeme Moyle Chelsea and Westminster Hospital NHS Foundation Trust
Anton Pozniak
Anton Pozniak London School of Hygiene & Tropical Medicine
Giovanni Di Perri
Giovanni Di Perri University of Turin
Munir Pirmohamed
Munir Pirmohamed University of Liverpool
Stephen A. Ward
Stephen A. Ward Liverpool School of Tropical Medicine
David M. Burger
David M. Burger Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering studying Medicine in the USA, several related online degrees and career pathways can help you begin or advance your healthcare journey. For those drawn to preventive medicine and wellness, earning a nutritionist online degree is a great way to build expertise in nutrition science and dietary health.

Aspiring leaders in healthcare administration might explore a cahme accredited online mha for career advancement in hospital and health system management. Nurses looking to upskill without added clinical hours can enroll in rn to bsn programs no clinicals, which are designed for working professionals to complete coursework entirely online.

For registered nurses who wish to move into advanced practice or leadership, the shortest online dnp program options offer flexible and streamlined pathways to a Doctor of Nursing Practice degree. Each of these programs offers flexibility, diverse specialties, and can fit around current work or family commitments, making them ideal for adult learners and busy professionals.

Best Scientists Citing David Back

Trending Scientists

Recently Published Articles